Logo image of B7E.DE

BLUE CAP AG (B7E.DE) Stock Fundamental Analysis

FRA:B7E - Deutsche Boerse Ag - DE000A0JM2M1 - Common Stock - Currency: EUR

18  +0.3 (+1.69%)

Fundamental Rating

4

Overall B7E gets a fundamental rating of 4 out of 10. We evaluated B7E against 102 industry peers in the Capital Markets industry. B7E has only an average score on both its financial health and profitability. B7E has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year B7E has reported negative net income.
B7E had a positive operating cash flow in the past year.
B7E had positive earnings in 4 of the past 5 years.
B7E had a positive operating cash flow in each of the past 5 years.
B7E.DE Yearly Net Income VS EBIT VS OCF VS FCFB7E.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

1.2 Ratios

The Return On Assets of B7E (-4.39%) is comparable to the rest of the industry.
B7E has a Return On Equity (-13.01%) which is in line with its industry peers.
B7E's Return On Invested Capital of 1.97% is fine compared to the rest of the industry. B7E outperforms 62.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for B7E is below the industry average of 8.29%.
Industry RankSector Rank
ROA -4.39%
ROE -13.01%
ROIC 1.97%
ROA(3y)-0.43%
ROA(5y)1.69%
ROE(3y)-1.32%
ROE(5y)4.18%
ROIC(3y)4%
ROIC(5y)4.74%
B7E.DE Yearly ROA, ROE, ROICB7E.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

1.3 Margins

B7E's Operating Margin of 1.89% is in line compared to the rest of the industry. B7E outperforms 58.10% of its industry peers.
B7E's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 49.50%, B7E is doing good in the industry, outperforming 69.52% of the companies in the same industry.
In the last couple of years the Gross Margin of B7E has remained more or less at the same level.
Industry RankSector Rank
OM 1.89%
PM (TTM) N/A
GM 49.5%
OM growth 3Y-46.81%
OM growth 5Y-29.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.7%
GM growth 5Y0.6%
B7E.DE Yearly Profit, Operating, Gross MarginsB7E.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

B7E has more shares outstanding than it did 1 year ago.
The number of shares outstanding for B7E has been increased compared to 5 years ago.
The debt/assets ratio for B7E is higher compared to a year ago.
B7E.DE Yearly Shares OutstandingB7E.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
B7E.DE Yearly Total Debt VS Total AssetsB7E.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 1.97 indicates that B7E is not a great score, but indicates only limited risk for bankruptcy at the moment.
B7E has a Altman-Z score of 1.97. This is in the better half of the industry: B7E outperforms 72.38% of its industry peers.
B7E has a debt to FCF ratio of 7.36. This is a slightly negative value and a sign of low solvency as B7E would need 7.36 years to pay back of all of its debts.
B7E's Debt to FCF ratio of 7.36 is fine compared to the rest of the industry. B7E outperforms 76.19% of its industry peers.
A Debt/Equity ratio of 0.78 indicates that B7E is somewhat dependend on debt financing.
B7E's Debt to Equity ratio of 0.78 is fine compared to the rest of the industry. B7E outperforms 60.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 7.36
Altman-Z 1.97
ROIC/WACCN/A
WACCN/A
B7E.DE Yearly LT Debt VS Equity VS FCFB7E.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

B7E has a Current Ratio of 1.53. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
B7E's Current ratio of 1.53 is fine compared to the rest of the industry. B7E outperforms 79.05% of its industry peers.
A Quick Ratio of 1.08 indicates that B7E should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.08, B7E is doing good in the industry, outperforming 68.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.08
B7E.DE Yearly Current Assets VS Current LiabilitesB7E.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.34% over the past year.
B7E shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.57%.
Measured over the past years, B7E shows a quite strong growth in Revenue. The Revenue has been growing by 9.27% on average per year.
EPS 1Y (TTM)0.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.23%
Revenue 1Y (TTM)-11.57%
Revenue growth 3Y5.57%
Revenue growth 5Y9.27%
Sales Q2Q%-11.12%

3.2 Future

The Earnings Per Share is expected to grow by 52.67% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -0.47% on average over the next years.
EPS Next Y676.88%
EPS Next 2Y76.19%
EPS Next 3Y52.67%
EPS Next 5YN/A
Revenue Next Year-23.66%
Revenue Next 2Y-10.78%
Revenue Next 3Y-5.7%
Revenue Next 5Y-0.47%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
B7E.DE Yearly Revenue VS EstimatesB7E.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
B7E.DE Yearly EPS VS EstimatesB7E.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4 6 8 10

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for B7E. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 20.18 indicates a rather expensive valuation of B7E.
Compared to the rest of the industry, the Price/Forward Earnings ratio of B7E indicates a somewhat cheap valuation: B7E is cheaper than 62.86% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of B7E to the average of the S&P500 Index (22.10), we can say B7E is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 20.18
B7E.DE Price Earnings VS Forward Price EarningsB7E.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

91.43% of the companies in the same industry are more expensive than B7E, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, B7E is valued cheaper than 95.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.35
EV/EBITDA 4.62
B7E.DE Per share dataB7E.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

B7E's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as B7E's earnings are expected to grow with 52.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y76.19%
EPS Next 3Y52.67%

More info and screens

3

5. Dividend

5.1 Amount

B7E has a Yearly Dividend Yield of 3.61%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 6.34, B7E pays a bit more dividend than its industry peers.
B7E's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 3.61%

5.2 History

The dividend of B7E decreases each year by -14.87%.
Dividend Growth(5Y)-14.87%
Div Incr Years2
Div Non Decr Years4
B7E.DE Yearly Dividends per shareB7E.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of B7E are negative and hence is the payout ratio. B7E will probably not be able to sustain this dividend level.
DP-46.81%
EPS Next 2Y76.19%
EPS Next 3Y52.67%
B7E.DE Yearly Income VS Free CF VS DividendB7E.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

More info and screens

BLUE CAP AG

FRA:B7E (3/6/2025, 7:00:00 PM)

18

+0.3 (+1.69%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-23 2024-10-23
Earnings (Next)03-11 2025-03-11/amc
Inst Owners25.66%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap80.82M
Analysts82.86
Price Target30.91 (71.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.61%
Yearly Dividend0.45
Dividend Growth(5Y)-14.87%
DP-46.81%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.9%
PT rev (3m)23.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.18
P/S 0.31
P/FCF 6.35
P/OCF 4.36
P/B 1
P/tB 3.14
EV/EBITDA 4.62
EPS(TTM)-2.34
EYN/A
EPS(NY)0.89
Fwd EY4.96%
FCF(TTM)2.83
FCFY15.75%
OCF(TTM)4.13
OCFY22.96%
SpS57.27
BVpS17.92
TBVpS5.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.39%
ROE -13.01%
ROCE 2.89%
ROIC 1.97%
ROICexc 2.45%
ROICexgc 4.07%
OM 1.89%
PM (TTM) N/A
GM 49.5%
FCFM 4.95%
ROA(3y)-0.43%
ROA(5y)1.69%
ROE(3y)-1.32%
ROE(5y)4.18%
ROIC(3y)4%
ROIC(5y)4.74%
ROICexc(3y)4.92%
ROICexc(5y)6.13%
ROICexgc(3y)7.72%
ROICexgc(5y)7.89%
ROCE(3y)5.94%
ROCE(5y)7%
ROICexcg growth 3Y-38.65%
ROICexcg growth 5Y-19.93%
ROICexc growth 3Y-48.01%
ROICexc growth 5Y-26.87%
OM growth 3Y-46.81%
OM growth 5Y-29.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.7%
GM growth 5Y0.6%
F-Score5
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 7.36
Debt/EBITDA 2.1
Cap/Depr 23.33%
Cap/Sales 2.27%
Interest Coverage 0.89
Cash Conversion 62.14%
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 1.08
Altman-Z 1.97
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)27.02%
Cap/Depr(5y)44.24%
Cap/Sales(3y)2.2%
Cap/Sales(5y)2.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.23%
EPS Next Y676.88%
EPS Next 2Y76.19%
EPS Next 3Y52.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.57%
Revenue growth 3Y5.57%
Revenue growth 5Y9.27%
Sales Q2Q%-11.12%
Revenue Next Year-23.66%
Revenue Next 2Y-10.78%
Revenue Next 3Y-5.7%
Revenue Next 5Y-0.47%
EBIT growth 1Y-28.67%
EBIT growth 3Y-43.84%
EBIT growth 5Y-22.68%
EBIT Next Year817.24%
EBIT Next 3Y107.88%
EBIT Next 5Y59.46%
FCF growth 1Y393.52%
FCF growth 3Y53.59%
FCF growth 5YN/A
OCF growth 1Y527.81%
OCF growth 3Y15.88%
OCF growth 5Y54.35%